GENERAL COMMENTS
This is an interesting study and a carefully written protocol that should make a nice contribution to the literature. My only major comment is that it would be good to make sure all aspects of SPIRIT guidelines are covered (a number of elements are missing). For example, there is no mention of how randomisation will be done. There is no mention of concealment and blinding (although as this is all online these two are implicitly managed).
There is no mention of data management. There is no mention of harms and auditing. There is no mention of trial governance (e.g. DMEC/TSC) or to say this is not being done due to phase of trial. I also had a number of more minor comments:
-Given BMJ open is an international journal, consider quoting international statistics about prevalence of depression rather than Australia specific ones in opening paragraph.
-When describing the rationale OGM training, be clear that over general memory is independence of valence (i.e. is found for pos, neg and neutral memories).
-Sentence 'c-MEST has been show to affect the proposed cognitive mechanism of change' took me a while to processconsider saying it changed memory specificity? -It is interesting not to include any kind of facilitation, given that guided self help tends to out perform non guided self help in the literature (p.6). it might be worth unpacking rationale for this a bit more? -The c-MEST intervention jumps between past and future tense in places -best to stick to future tense? -Clarify which time point is primary outcome? P.8 and in abstract -Clarify over which time course you will assess change in mediators and outcome for mediation analysis (e.g.primary mediation will look at change in mediator from t1 to 2, predicting change in t2 to t3). It would be useful to comment on power for mediation analyses of these kind.
-It might be worth being clear about how risk will be managed. If people score above cut off on suicide ideation attributes scale, will this impact on their ongoing involvement in study?
-It might be worth being clear about what will happen if participants in control group change meds or seek other treatment during study follow up period. It does not seem ethical to deny them access to routine care for duration of follow up period, but relevant to capture this information as likely to bias results somewhat (i.e. minimise any chance for treatment to work).
-It would be good to clarify when last recruitment is planned (to be sure this protocol has been submitted prior to recruitment of last patient). Please leave your comments for the authors below. This is an interesting study and a carefully written protocol that should make a nice contribution to the literature. My only major comment is that it would be good to make sure all aspects of SPIRIT guidelines are covered (a number of elements are missing). For example, there is no mention of how randomisation will be done. There is no mention of concealment and blinding (although as this is all online these two are implicitly managed). There is no mention of data management. There is no mention of harms and auditing. There is no mention of trial governance (e.g. DMEC/TSC) or to say this is not being done due to phase of trial. I also had a number of more minor comments:
REVIEWER
Thank you for your comments. -Randomisation method is described in paragraph 2 of page 6. -Blinding of researchers to allocation is noted in paragraph 2 of page 9 -Data management is discussed in greater length now in paragraph 2 of page 9 -Harms and auditing is now discussed in paragraph 1, page 11 -Governance is now discussed more clearly in paragraph 3 of page 10.
Given BMJ open is an international journal, consider quoting international statistics about prevalence of depression rather than Australia specific ones in opening paragraph. Such statistics have now been discussed in paragraph 1 of page 3. ` -When describing the rationale OGM training, be clear that over general memory is independence of valence (i.e. is found for pos, neg and neutral memories). This has now been made clearer on page 3.
Sentence 'c-MEST has been show to affect the proposed cognitive mechanism of change' took me a while to process -consider saying it changed memory specificity? The expression is now improved (paragraph 1 of page 5) -It is interesting not to include any kind of facilitation, given that guided self help tends to out perform non guided self help in the literature (p.6). it might be worth unpacking rationale for this a bit more? Further rationale regarding it being unguided, and therefore needing very few resources and appropriate for broad rollout, is noted now in paragraph 3 of page 11.
-
The c-MEST intervention jumps between past and future tense in places -best to stick to future tense? Yes, this is now change to be only future tense (pages 6-7).
Clarify which time point is primary outcome? P.8 and in abstract This is now clarified on page 7 and in the abstract as post-intervention.
Clarify over which time course you will assess change in mediators and outcome for mediation analysis (e.g.primary mediation will look at change in mediator from t1 to 2, predicting change in t2 to t3). It would be useful to comment on power for mediation analyses of these kind. The mediation analysis has been clarified, and comment is made about power for this analysis (both page 9).
It might be worth being clear about how risk will be managed. If people score above cut off on suicide ideation attributes scale, will this impact on their ongoing involvement in study? This has been made clearer now in the section discussing risk management (first paragraph on page 11).
It might be worth being clear about what will happen if participants in control group change meds or seek other treatment during study follow up period. It does not seem ethical to deny them access to routine care for duration of follow up period, but relevant to capture this information as likely to bias results somewhat (i.e. minimise any chance for treatment to work). This is now discussed clearly -it will be controlled for in analysis (last paragraph of page 9) -It would be good to clarify when last recruitment is planned (to be sure this protocol has been submitted prior to recruitment of last patient). The actual date recruitment commenced, and the planned finish of recruitment, in the 1 st quarter of 2019, is now stated clearly (second paragraph of page 11).
Reviewer: 2 Reviewer Name: Craig Steel Institution and Country: Oxford Health NHS Trust, UK Please state any competing interests or state 'None declared': none Thank you for you feedback and comments.
Please leave your comments for the authors below Well written protocol. Two points, one of them very minor.
First, it was not clear why those who score above 21 on the PHQ are excluded, this would seem important for generalisability of results. This score will mean participants will have either moderate or moderately-severe depression, according to the PHQ. Those with highly severe depression were omitted in the context of the trial not having resources and provision for assertive follow-up for highly unwell participants. This was at the request of the University Research Ethics Committee, and is now stated clearly on page 6. Second, minor point, prior to reference 17, these interventions can be effective (they are not all effective by default) This has been amended to read "can be effective" (page 4).
